-
2022-502611-10-00
5
2020-11-24
Primary Progressive Multiple Sclerosis (PPMS)
-
2024-514404-13-00
5
2020-10-01
Atopic Dermatitis
-
2022-502841-91-00
5
2020-08-12
Crohn’s Disease
-
2024-510626-89-00
5
2019-11-18
Non-Alcoholic Steatohepatitis (NASH)
-
2023-504718-31-00
10
2019-10-19
Moderately to Severely Active Ulcerative Colitis
-
2023-510357-42-00
5
2019-05-22
hormone receptor (HR)-positive, HER2-negative,
early breast cancer (EB
-
2022-502937-24-00
5
2019-01-02
Atopic Dermatitis
-
2023-506921-12-00
5
2018-12-27
ER+/HER2- Breast Cancer
-
2023-503378-19-00
5
2018-08-23
Chronic Plaque Psoriasis
-
2023-504951-29-00
5
2017-07-27
Chron's Disease
-
2023-509671-17-00
5
2017-07-12
Breast Cancer
-
2023-507705-34-00
5
2025-08-29
Moderate to Severe Active Ulcerative Colitis
-
2024-510826-16-00
5
2025-04-07
Rheumatoid Arthritis
-
2024-512562-34-00
4
2025-02-24
Type 2 Diabetes Mellitus
-
2023-506664-14-00
5
2024-10-24
Rheumatoid Arthritis
-
2024-511360-87-00
5
2024-10-02
hidradenitis suppurativa (HS)
-
2023-505433-27-00
5
2024-08-13
Atopic Dermatitis
-
2022-502677-42-00
5
2024-07-24
Type 2 diabetes
-
2024-511408-18-00
5
2024-07-15
Type 2 Diabetes inadequately controlled with dapagliflozin with or wit
-
2023-505857-42-00
4
2024-04-19
Chronic Kidney Disease, Type 2 diabetes
-
2023-504564-42-00
4
2024-04-08
Moderate to Severe Rheumatoid Arthritis
-
2022-501310-57-00
4
2024-02-05
Endometriosis related pain
-
2023-503790-37-00
5
2024-01-09
Post-Menopausal Osteoporosis
-
2022-503160-33-00
5
2023-12-15
Hidradenitis Suppurativa